Kura Oncology, Inc.KURANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+36.6%
5Y CAGR+30.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+36.6%/yr
vs +30.8%/yr prior
5Y CAGR
+30.8%/yr
Recent acceleration
Acceleration
+5.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $119.98M | +55.6% |
| 2024 | $77.11M | +52.5% |
| 2023 | $50.57M | +7.5% |
| 2022 | $47.05M | +1.1% |
| 2021 | $46.54M | +48.6% |
| 2020 | $31.31M | +59.3% |
| 2019 | $19.65M | +22.1% |
| 2018 | $16.10M | +66.8% |
| 2017 | $9.65M | +21.2% |
| 2016 | $7.96M | - |